课题基金 / 基金详情

Vitamin D and Calcium Homeostasis in Relation to Type 2 Diabetes

Vitamin D and Calcium Homeostasis in Relation to Type 2 Diabetes
维生素 D 和钙稳态与 2 型糖尿病的关系
批准号:
7663139
负责人:
Anastassios G Pittas
金额:
$34.16万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-30 至 2011-07-31

项目摘要

项目成果

Anastassios G Pittas的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):2型糖尿病(t2DM)的发病率在全国和全球范围内以惊人的速度增加,仅在美国每年就诊断出超过100万例新病例。虽然减肥已被证明在延缓糖尿病方面是成功的,但它很难实现并长期保持。因此,迫切需要识别与体重无关的环境和容易改变的危险因素,以防止2型糖尿病发病率的增加。维生素D和钙是两种营养因素,根据动物和人类研究,包括我们自己的观察数据,被怀疑是糖尿病风险的调节剂。然而,我们对维生素D和钙对糖尿病风险的临床影响程度的认识存在重大差距,包括其与2型糖尿病相关的潜在生理作用机制的不确定性。目前,缺乏数据限制了维生素D和钙作为预防2型糖尿病的可行营养干预措施的有效性。拟议研究的中心假设是,维生素D和钙不足是发生2型糖尿病的风险因素,该风险由胰腺β细胞功能、胰岛素敏感性和全身炎症的变化介导。我们计划通过双重方法(观察性研究和实验性人体试验)来测试我们的主要假设,以实现以下2个特定目标。(一).在一项大型前瞻性队列研究(护士健康研究)中,评估维生素D状态与2型糖尿病风险之间的关联程度。工作假设是,维生素D状态,如血清25 OHD水平测定,与2型糖尿病风险呈负相关。该关联将被量化(2)。在一项为期3个月的随机安慰剂对照试验中,确定维生素D和钙补充剂对β细胞功能、胰岛素敏感性、葡萄糖耐量和全身炎症的影响,该试验在有2型糖尿病风险的成人中进行,给予维生素D3和碳酸钙(2x2析因设计)。工作假设是维生素D和钙补充剂改善β细胞功能和胰岛素敏感性(主要结果)以及全身炎症和葡萄糖耐量(次要结果)。我们的研究结果将提供新的和重要的数据,将作为基础,合理整合这些营养素到传统的医疗保健,以减轻2型糖尿病的负担。
英文摘要
DESCRIPTION (provided by applicant): The incidence of type 2 Diabetes Mellitus (t2DM) is increasing at an alarming rate both nationally and worldwide with more than 1 million new cases per year diagnosed in the US alone. Although weight- loss has been shown to be successful in delaying diabetes, it is difficult to achieve and maintain long- term. Therefore, identification of weight-independent environmental and easily modified risk factors is urgently needed to prevent the increase in the incidence of t2DM. Vitamin D and calcium are two nutritional factors that have been suspected as modifiers of diabetes risk based on animal and human studies including our own observational data. However, there are critical gaps in our knowledge about the magnitude of the clinical effect of vitamin D and calcium on diabetes risk, including uncertainty about their potential physiologic mechanism of action in relation to t2DM. Currently, this lack of data limits the usefulness of vitamin D and calcium as feasible nutritional interventions for prevention of t2DM. The central hypothesis of the proposed study is that, vitamin D and calcium insufficiency are risk factors for the development of t2DM and that the risk is mediated by changes in pancreatic beta- cell function, insulin sensitivity, and systemic inflammation. We plan to test our main hypothesis by pursuing a dual approach (observational study and experimental human trial) to achieve the following 2 specific aims. (1). Assess the magnitude of the association between vitamin D status and risk of t2DM in a nested case-control study design in women in a large prospective cohort, the Nurses' Health Study. The working hypothesis is that vitamin D status, as measured by serum 25OHD level, is inversely associated with t2DM risk. The association will be quantified (2). Determine the effects of vitamin D and Calcium supplementation on beta-cell function, insulin sensitivity, glucose tolerance and systemic inflammation in a 3-month randomized placebo-controlled trial of adults at risk for t2DM given vitamin D3 and calcium carbonate (2x2 factorial design). The working hypothesis is that vitamin D and calcium supplementation improves beta-cell function and insulin sensitivity (primary outcomes) and systemic inflammation and glucose tolerance (secondary outcomes). Our results will provide novel and important data that will serve as the foundation for the rational integration of these nutrients into conventional medical care to ameliorate t2DM burden.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vitamin D and type 2 diabetes (D2d)
  • 批准号:
    8481985
  • 项目类别:
  • 资助金额:
    $985.41万
  • 财政年份:
    2013
  • 负责人:
    Anastassios G Pittas
  • 依托单位:
Vitamin D and type 2 diabetes (D2d)
  • 批准号:
    8660059
  • 项目类别:
  • 资助金额:
    $1061.06万
  • 财政年份:
    2013
  • 负责人:
    Anastassios G Pittas
  • 依托单位:
Vitamin D and Type 2 Diabetes (D2d)
  • 批准号:
    9974505
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2013
  • 负责人:
    Anastassios G Pittas
  • 依托单位:
Vitamin D and type 2 diabetes (D2d)
  • 批准号:
    9266395
  • 项目类别:
  • 资助金额:
    $655.0万
  • 财政年份:
    2013
  • 负责人:
    Anastassios G Pittas
  • 依托单位:
海外基金